ATE499946T1 - Verwendung von hgf für die behandlung von ischämischen erkrankungen der extremitäten - Google Patents

Verwendung von hgf für die behandlung von ischämischen erkrankungen der extremitäten

Info

Publication number
ATE499946T1
ATE499946T1 AT99935079T AT99935079T ATE499946T1 AT E499946 T1 ATE499946 T1 AT E499946T1 AT 99935079 T AT99935079 T AT 99935079T AT 99935079 T AT99935079 T AT 99935079T AT E499946 T1 ATE499946 T1 AT E499946T1
Authority
AT
Austria
Prior art keywords
hgf
extremities
treatment
ischemic disease
administered
Prior art date
Application number
AT99935079T
Other languages
English (en)
Inventor
Tomokazu Nagano
Ikue Kudo
Takao Kawamura
Mutsuo Taiji
Hiroshi Noguchi
Shunsuke Tani
Hiroo Maeda
Original Assignee
Nakamura Toshikazu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nakamura Toshikazu filed Critical Nakamura Toshikazu
Application granted granted Critical
Publication of ATE499946T1 publication Critical patent/ATE499946T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT99935079T 1998-08-05 1999-08-04 Verwendung von hgf für die behandlung von ischämischen erkrankungen der extremitäten ATE499946T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22217098 1998-08-05
JP626199 1999-01-13
PCT/JP1999/004249 WO2000007615A1 (fr) 1998-08-05 1999-08-04 Preparations destinees a l'administration d'un facteur de croissance des hepatocytes

Publications (1)

Publication Number Publication Date
ATE499946T1 true ATE499946T1 (de) 2011-03-15

Family

ID=26340360

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99935079T ATE499946T1 (de) 1998-08-05 1999-08-04 Verwendung von hgf für die behandlung von ischämischen erkrankungen der extremitäten

Country Status (10)

Country Link
US (1) US6887477B1 (de)
EP (1) EP1103269B1 (de)
KR (1) KR100761675B1 (de)
CN (1) CN1222310C (de)
AT (1) ATE499946T1 (de)
AU (1) AU5065599A (de)
CA (1) CA2339378A1 (de)
DE (1) DE69943240D1 (de)
TW (1) TWI263502B (de)
WO (1) WO2000007615A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001286221B2 (en) * 2000-09-13 2006-09-28 Chugai Seiyaku Kabushiki Kaisha Remedies for ischemic diseases
KR100562824B1 (ko) 2002-03-20 2006-03-23 주식회사 바이로메드 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자
ATE377427T1 (de) * 2004-03-09 2007-11-15 Tohoku Technoarch Co Ltd Verwendung des hepatozyten-wachstumsfaktors zur förderung der induktion der vaskulären differenzierung
WO2008102452A1 (ja) * 2007-02-22 2008-08-28 Kringle Pharma Inc. Ｈｇｆ製剤
US20090202606A1 (en) * 2008-01-25 2009-08-13 Viromed Co., Ltd. Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor
MX2016005006A (es) 2013-10-22 2016-07-14 Viromed Co Ltd Composicion para prevenir a tratar la esclerosis lateral amiotrofica usando dos o mas isoformas del factor de crecimiento de hepatocito.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2777678B2 (ja) 1990-06-11 1998-07-23 敏一 中村 組換ヒト肝実質細胞増殖因子及びその製造方法
JP3283288B2 (ja) 1991-03-08 2002-05-20 電気化学工業株式会社 生理活性ペプチド製剤
JP3395181B2 (ja) * 1991-07-26 2003-04-07 東レ株式会社 造血幹細胞増加剤
JP3394982B2 (ja) * 1991-11-07 2003-04-07 敏一 中村 ガン療法用副作用防止剤
US6498144B1 (en) * 1993-10-18 2002-12-24 North Shore - Long Island Jewish Research Institute Use of scatter factor to enhance angiogenesis
US5837676A (en) * 1993-10-18 1998-11-17 Long Island Jewish Medical Center Use of scatter factor to enhance angiogenesis
JP3818322B2 (ja) * 1994-04-28 2006-09-06 敏一 中村 コラーゲン分解促進剤
JP3977452B2 (ja) * 1995-02-27 2007-09-19 敏一 中村 動脈疾患治療剤
AU7254896A (en) * 1995-10-05 1997-04-28 Genentech Inc. Improved angiogenesis using hepatocyte growth factor
AU718500B2 (en) * 1997-01-23 2000-04-13 Sumitomo Pharmaceuticals Company, Limited Remedies for diabetes
JP4865936B2 (ja) * 1997-03-15 2012-02-01 中村 敏一 急性腎不全治療用ｈｇｆ

Also Published As

Publication number Publication date
CN1315867A (zh) 2001-10-03
CN1222310C (zh) 2005-10-12
US6887477B1 (en) 2005-05-03
EP1103269A1 (de) 2001-05-30
EP1103269B1 (de) 2011-03-02
WO2000007615A1 (fr) 2000-02-17
CA2339378A1 (en) 2000-02-17
EP1103269A4 (de) 2004-11-03
TWI263502B (en) 2006-10-11
KR20010072207A (ko) 2001-07-31
AU5065599A (en) 2000-02-28
KR100761675B1 (ko) 2007-10-04
DE69943240D1 (de) 2011-04-14

Similar Documents

Publication Publication Date Title
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
ATE241365T1 (de) Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
FI922325A0 (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
DE69426334D1 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
ES2196027T3 (es) Tratamiento de enfermedades vasculares degenerativas mediante modulacion de la produccion o actividad del oxido nitrico exogeno.
DE60115432D1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
ATE499946T1 (de) Verwendung von hgf für die behandlung von ischämischen erkrankungen der extremitäten
KR950031085A (ko) 표피증식 질환 치료용 의약 조성물
Reiz et al. EMLA--a eutectic mixture of local anaesthetics for topical anaesthesia
KR910005858A (ko) 지방산 요법
ATE126061T1 (de) Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum.
ATE185274T1 (de) Therapeutisches mittel gegen drohenden abortus
SE7605232L (sv) 1,3-polyhalogen-2-propyletrar
ATE247462T1 (de) Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
DE69312297D1 (de) Verwendung von 2-[4-(-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphtoquinon zur behandlung von krebs
ES2077698T3 (es) Agente terapeutico para la gangrena diabetica.
FI880027A0 (fi) Antibakteriellt lyofiliserat preparat.
ATE372127T1 (de) Präparation zur kontinuierlichen intravenösen verabreichung
KR900017599A (ko) 종양 치료용 약학 조성물
NL7513892A (en) Ascorbic acid medicaments for external use - as nasal decongestants and to promote resistance to infection
Himwich et al. Effect of Neosynephrin on Gaseous Exchange of the Brain.
Kessler et al. Methoxyflurane (penthrane) anesthesia effect on histamine stimulated gastric secretion in the chicken
JPS6183121A (ja) 虚血性潰瘍治療剤
KR890001555A (ko) 요산 배설용 조성물

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties